The eIF2-alpha kinase HRI is a novel therapeutic target in multiple myeloma

Nicholas Burwick, Michael Y. Zhang, Pilar de la Puente, Abdel Kareem Azab, Teresa S. Hyun, Melisa Ruiz-Gutierrez, Marilyn Sanchez-Bonilla, Tomoka Nakamura, Jeffrey J. Delrow, Vivian L. MacKay, Akiko Shimamura

Research output: Contribution to journal › Article › peer-review

20 Scopus citations

Fingerprint

Dive into the research topics of 'The eIF2-alpha kinase HRI is a novel therapeutic target in multiple myeloma'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Biochemistry, Genetics and Molecular Biology

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience